PDCD1LG2 and neoplasm: Tumor cells expressing PD‐L1 and PD‐L2 can activate PD‐1 on T cells, inhibiting T cell immune responses, promoting apoptosis of lymph node antigen‐specific T cells, and reducing apoptosis of Tregs and macrophages.